Clinical trial
A European Multicenter Open-Label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
NCT00842829 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A European Multicenter Open-Label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
- Lead sponsor
- Cephalon
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- May 31, 2011
- Enrollment
- 330 (actual)
- Sites
- 123
Conditions
As the registry lists them; a condition with its own page is linked.